Gang Yang1, Gang Zhao1, Jian Zhang2, Sichuan Gao2, Tingmei Chen3, Shijia Ding3, Yun Zhu4. 1. Department of Orthopedics, Fuling Center Hospital of Chongqing City, Chongqing, 408000, China. 2. Department of Orthopedics, The First Affiliated Hospital, Chongqing Medical University, Youyi Road No. 1, Chongqing, 400016, China. 3. Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China. 4. Department of Orthopedics, Fuling Center Hospital of Chongqing City, Chongqing, 408000, China. zhuyun79@163.com.
Abstract
INTRODUCTION: Osteonecrosis of the femoral head (ONFH), one of the widespread orthopedic diseases with a decrease in bloodstream to the femoral head, is frequently accompanied by cellular death, trabecula fracture, and collapse of the articular surface. The exactly pathological mechanism of ONFH remains to explore and further identify. OBJECTIVES: The aim was to identify the global urinary metabolic profiling of ONFH and to detect biomarkers of ONFH. METHODS: Urine samples were collected from 26 ONFH patients and 26 healthy people. Ultra-performance liquid chromatography-quadrupole time of flight tandem mass spectrometry (UPLC-QTOF/MS) in combination with multivariate statistical analysis was developed and performed to identify the global urinary metabolic profiling of ONFH. RESULTS: The urinary metabolic profiling of ONFH group was significantly separated from the control group by multivariate statistical analysis. 33 distinctly differential metabolites were detected between the ONFH patients and healthy people. Sulfate, urea, Deoxycholic acid and PE(14:0/14:1(9Z)) were screened as the potential biomarkers of ONFH. In addition, the up/down-regulation of sulfur metabolism, cysteine and methionine metabolism, glycerophospholipid metabolism, and histidine metabolism were clearly be associated with the ONFH pathogenic progress. CONCLUSION: Our results suggested that metabolomics could serve as a promising approach for identifying the diagnostic biomarkers and elucidating the pathological mechanism of ONFH.
INTRODUCTION:Osteonecrosis of the femoral head (ONFH), one of the widespread orthopedic diseases with a decrease in bloodstream to the femoral head, is frequently accompanied by cellular death, trabecula fracture, and collapse of the articular surface. The exactly pathological mechanism of ONFH remains to explore and further identify. OBJECTIVES: The aim was to identify the global urinary metabolic profiling of ONFH and to detect biomarkers of ONFH. METHODS: Urine samples were collected from 26 ONFH patients and 26 healthy people. Ultra-performance liquid chromatography-quadrupole time of flight tandem mass spectrometry (UPLC-QTOF/MS) in combination with multivariate statistical analysis was developed and performed to identify the global urinary metabolic profiling of ONFH. RESULTS: The urinary metabolic profiling of ONFH group was significantly separated from the control group by multivariate statistical analysis. 33 distinctly differential metabolites were detected between the ONFH patients and healthy people. Sulfate, urea, Deoxycholic acid and PE(14:0/14:1(9Z)) were screened as the potential biomarkers of ONFH. In addition, the up/down-regulation of sulfur metabolism, cysteine and methionine metabolism, glycerophospholipid metabolism, and histidine metabolism were clearly be associated with the ONFH pathogenic progress. CONCLUSION: Our results suggested that metabolomics could serve as a promising approach for identifying the diagnostic biomarkers and elucidating the pathological mechanism of ONFH.
Entities:
Keywords:
Biomarkers; Metabolomics; Osteonecrosis of the femoral head; UPLC–MS/MS; Urine
Authors: Steven H Back; Naga Suresh Adapala; Mary F Barbe; Nick C Carpino; Alexander Y Tsygankov; Archana Sanjay Journal: Cell Mol Life Sci Date: 2012-11-13 Impact factor: 9.261
Authors: Roberto Civinini; Antonio Capone; Christian Carulli; Fabrizio Matassi; Lorenzo Nistri; Massimo Innocenti Journal: J Mater Sci Mater Med Date: 2017-08-07 Impact factor: 3.896
Authors: C Zalavras; Z Dailiana; M Elisaf; E Bairaktari; P Vlachogiannopoulos; A Katsaraki; K N Malizos Journal: Eur J Clin Invest Date: 2000-03 Impact factor: 4.686